|
WORKSHOP
ON SIMIAN VIRUS-40 (SV-40):
A Possible Human Polyomavirus
The
following statement is an introduction for a more detailed packet
on SV-40 and animal viruses in the production of vaccines. Click
here
to order the complete packet.
Statement
by Barbara Loe Fisher, Co-Founder & President
National Vaccine Information Center
Workshop on Simian Virus-40 (SV-40): A Possible Human Polyomavirus
January 27-28, 1997
Bethesda, Maryland
The
National Vaccine Information Center (NVIC), which was founded in
1982 and represents health care consumers and health care professionals
concerned about vaccine safety, became actively involved in 1994
in researching reports of contamination of childhood vaccines with
animal viruses and the possibility that inter-species transfer of
animal viruses into humans via vaccines has had a negative impact
on public health. Our concern was that government health agencies
and industry had not adequately addressed many of the most important
questions that remained unanswered about the contamination of polio
vaccines with simian (monkey) viruses.
In
June 1994, NVIC sent a letter to HHS Secretary Donna Shalala in
which we reviewed documented evidence that polio vaccines have been
contaminated with simian viruses and that, not only has the public
not been adequately informed of this fact, but little has been done
to determine whether this contamination has impacted negatively
on the public health. In our letter we reviewed an article published
in the March 1992 issue of The Lancet in which attorney Walter Kyle
provided evidence that the human immunodeficiency virus (HIV) may
have been created after simian immunodeficiency virus (SIV) entered
the human population when African green monkey kidney tissues infected
with SIV were used to produce polio vaccines. The Kyle article pointed
out that scientists at the Food and Drug Administration and within
industry suspected as early as the 1950's and knew, by the mid-1970's,
that polio vaccine had been contaminated with simian viruses and
that at least one of these monkey viruses - SV-40 - was later found
to cause leukemia and cancerous tumors in lab animals.
Our
June 1994 letter to Secretary Shalala called on the government to
conduct genetic testing of all archived lots of polio vaccine for
the presence of simian viruses or virus-like particles and asked
that this testing be monitored and verified by an independent group
of doctors, scientists, and members of the public. In addition,
NVIC asked that the government release to the public all data gathered
from any previous testing on these and other vaccines and biological
products, as it relates to simian virus contamination, including
the isolation, identification and genetic sequencing of any virus
or virus-like particles, other than polio, which have been isolated
and identified in any polio vaccine or other biological produced
licensed by the FDA as safe for human use.
In
the September 1995 issue of THE VACCINE REACTION published by NVIC,
we reported that California pathologist and immunologist W. John
Martin, M.D., Ph.D., had published evidence that he had discovered
an atypical virus infecting some children and adults, who are suffering
from neurological, immune and psychiatric dysfunction, which is
genetically linked to the African green monkey. After eight years
of work culturing out stealth viruses from patients suffering from
immune and brain dysfunction, Martin and his colleagues reported
they used DNA sequence analysis to identify one of the viruses as
being of African green monkey origin. Dr. Martin subsequently made
a presentation at a Vaccine Safety Forum Workshop at the Institute
of Medicine in November 1995 expressing his concern about possible
contamination of polio vaccines with simian viruses and the need
to immediately determine the prevalence of stealth viruses of simian
origin in the U.S. population and whether these stealth viruses
may be contributing to chronic immune system and brain disorders
in children and adults.
In
the April 1996 issue of THE VACCINE REACTION, NVIC reported that
California microbiologist Howard B. Urnovitz, Ph.D., had provided
compelling evidence at the Eighth Annual Houston Conference on AIDS
in America that the human immunodeficiency virus Type 1 (HIV-1)
is a monkey-human hybrid that was created after more than 320,000
Africans were injected in the late 1950's with experimental live
oral polio vaccines contaminated with live simian immunodeficiency
virus (SIV). Pointing out that endogenous retroviruses can easily
recombine with fragments of other viruses, both human and animal,
and form new hybrid viruses called chimeras, Dr. Urnovitz explained
how SIV could have recombined with the normal genes of the Africans,
who received the contaminated vaccines, and created a monkey-human
hybrid now known as HIV-1.
The
published research of Illinois molecular pathologist Michael Carbone
and other scientists, who have discovered SV-40 genes and proteins
in patients with virulent forms of bone, lung and brain cancer,
contributes to the urgent need for federal health officials and
industry to seriously investigate the growing amount of evidence
that contamination of polio vaccines with monkey viruses may be
contributing to immune and neurological dysfunction in our population.
It is especially important in light of the fact that Dr. Martin's
work suggests that stealth viruses of simian origin can be transmitted
from human to human; Dr. Urnovitz's work suggests that simian viruses
can recombine with human viruses and form deadly genetic-human hybrid
viruses that can be transmitted from human to human; and scientists
studying the presence of SV-40 in humans suggest that SV-40 can
be transmitted from human to human, specifically mother to child.
Due
to the obvious lack of past or present technological capability
to guarantee that vaccines are not contaminated with unknown monkey
viruses, the National Vaccine Information Center maintains that
it is scientifically prudent and ethically responsible to stop producing
vaccines using monkey tissues in order to prevent the possibility
of cross-species transfer of animal viruses into the human population
via vaccines. No mother or father wants to risk the possibility
that monkey viruses may be put into their child's body, no matter
what federal disease control goal is used as justification and regardless
of whether or not there is proof that the presence of monkey viruses
in the human body causes illness.
The
ends do not justify the means. Making the decision that it is appropriate
to allow for the possibility that vaccines may be contaminated with
unknown monkey viruses without informing the public of that fact
is a betrayal of the public trust by public health officials and
pharmaceutical companies who should know better.
The
National Vaccine Information Center is calling for:
1) No more animal tissues to be used in the production of vaccines;
2) A scientific investigation conducted by independent researchers
outside of government and industry into the prevalence of viruses
of simian genetic origin in the U.S. population;
3) The creation of retrospective and prospective long term studies
conducted by independent researchers outside of government and industry
to evaluate whether viruses of simian origin introduced into the
human population via vaccines have played a role in the emergence
of HIV-1 as well as the rising incidence of immune and neurological
dysfunction such as cancer, chronic fatigue syndrome, unexplained
encephalopathies and neuropathies, developmental delays, and personality
and behavior disorders; and
4) A congressional investigation to illuminate for Congress and
the public how the mass vaccination research, development and policymaking
infrastructure operates in order to evaluate whether new, independent
oversight mechanisms should be created to insure that the public
health and safety is not compromised by current and future vaccines.
It is important that these steps and other actions be taken immediately
in part so that more complete scientific understanding of the etiology
of HIV-1, SV-40 associated cancers and other immune and brain disorders
may lead more quickly to the development of appropriate therapies
to restore normal immune and neurological function in affected children
and adults. With 200 viral and bacterial vaccines in the research
pipeline and a new AIDS vaccine being rushed to market, the National
Vaccine Information Center maintains that it is particularly important
that meaningful action be taken without delay in order to protect
the health of not only this generation but future generations of
Americans
More
on vaccines:
Aseptic meningitis as a complication
of mumps vaccination
Hepatitis A
Hepatitis
B
Infant Rotovirus
The Meningococcal Vaccine - Public Policy and Individual Choices
Pneumococcal
disease and vaccine
Whooping Cough or Pertussis
Adverse
effects of adjuvants in vaccines
First International Public Conference on Vaccination
Letter
to NEJM from Dr Andrew J Wakefield MB.,BS FRCS
Quotes: Medical Doctors Speak out on Vaccinations
Study Attempts Cover Up of Autism-Mercury
Link
CDC Plans For Mass Vaccination Of All
Children With AIDS Vaccine
Top Ten Vaccine Information Sources Recommended
by the National
Workshop on simian virus-40
Vaccines fueling autism epidemic?
Click here
to download this complete article that includes all of the above
listed sub articles. This document is approximately 150 pages (1.24
mg's) and it is in Adobe PDF format. If you do not have a copy of
Adobe Acrobat PDF reader, please download a free copy here.
|